Between the first and second
year of my master's program in
counseling psychology I had my
first experience with the famous
fungus. One of the many things
I learned during that session was
that everything I was being taught about the best that
psychotherapy had to offer, was available (and to a greater
level of phenomenological depth), through the plant.
Subsequent experiences with a popular empathogen
confirmed this view.
Awareness itself is often not
enough to lead to lasting
change. Implementing
one's integrated insights
requires acting in ways that
are congruent with what
was learned. This is what
differentiates between
having spiritual experiences
and living a spiritual life.
Two and a half years later, at the
beginning of my doctoral program in
counselor education at the University
of Idaho, I was able to begin an
in-depth academic study of the
psychospiritual uses of entheogens.
I obtained university approval
to conduct a qualitative study of
how psychedelic use can result
in psychological and/or spiritual
change. My intention was to write
a comprehensive dissertation that
linked psychedelic experiences with
traditional theoretical orientations of
psychotherapeutic change processes
and spiritual change processes.
Recognizing that my audience
would be fellow counselors and
psychologists, I decided to interview
mental health professionals as my
research participants, in order
to establish a level of credibility for their stories. I
interviewed and audio-taped 20 individuals, all of
whom had graduate degrees in one of the mental health
professions, and who had personal experience with
psychedelics for their own psychospiritual development.
Using a semi-structured interview format, I inquired
into the processes involved in how participants'
entheogenic experiences led to long-term change.
Employing the qualitative research tradition of grounded
theory, I allowed the categories to emerge from the data
inherent in the transcribed interviews. Data analysis
was performed using three levels of coding (open, axial,
and selective) and the constant comparative method of
grounded theory (Strauss & Corbin, 1998). From this
analysis of the relationship between variables, a 5-stage
process model emerged.
Attention to these five
processes will increase
the likelihood of positive
outcomes, regardless of
the population or disorder
being treated.
The I-5 model
Intention: Intention sets the stage for the phenomena
of the experience itself, and what is done subsequently.
Preparing for a therapeutic psychedelic session includes
attending to the set and setting variables that will affect
the experience.
Ingestion: Both the chemical agent and the dosage of
that agent are included here. Drug and dosage should be
tied to the intention of the experiencer, as particular drugs
at particular doses in particular people will be more or less
appropriate.
Insight: Once the doors of
perception are opened, what
happens? A wide range of
perceptual experiences such as
symbolic imagery, activation of
cognitive/emotional schemas, or
interpersonal connections may
manifest. Increased self-awareness is
generally facilitated by psychedelics'
ability to suspend one's usual defense
mechanisms.
Integration: Integration involves
making sense of the phenomena
experienced. This begins during the
session, but often needs to continue
in the following days and weeks. As
one research participant succinctly
put it, "The light of reason and the
element of time" are needed to fully
integrate psychedelic experiences.
Implementation: Awareness
itself is often not enough to lead to lasting change.
Implementing one's integrated insights requires acting in
ways that are congruent with what was learned. This is
what differentiates between having spiritual experiences
and living a spiritual life.
This five-stage model differs from previous models in
its comprehensive description of the various processes
involved in entheogen-facilitated psychospiritual change.
The standing models of psychedelic psychotherapy
have addressed each of these components, in various
combinations, and to various degrees (such as a focus on
set and setting, or high dose vs. low dose, see Fadiman,
1965; Grof, 1975; Leary, Litwin, & Metzner, 1963;
Leuner, 1967; Masters & Houston, 1966; and Sherwood,
Stolaroff, & Harman, 1962). Models from the 1960's often subsumed implementation as a
part of integration. This may be an artifact of the psychodynamic influence of the times (with
psychodynamic psychotherapy's emphasis on insight and integration). Contemporary views of
human change processes in the field of psychotherapy require an explicit focus on how therapy
sessions lead to behavioral changes after therapy ends.
It is my hope that this model can help guide the human-trials research of psychedelic
psychotherapy that has recently resurfaced (thanks in large parts to the efforts of
MAPS). Attending to these five processes will increase the likelihood of positive
therapeutic outcomes, regardless of the population or disorder being treated.
Additionally, attention to the unique psychospiritual outcomes of psychedelic
sessions, apart from predetermined desired goals (i.e., healing of traumatic
wounds, or reduction in obsessive-compulsive behavior) can help researchers
identify therapeutically important outcomes variables not included in the original
research design.
My current research interest involves linking the common factors of
psychotherapy (those factors that are transtheoretical) with the processes
identified in the I-5 model. Outcome research of psychotherapeutic change
continues to highlight the fact that client-related variables, rather than specific
therapist interventions, constitute the most influential variables in the change
process (Hubble, Duncan, & Miller, 1999). These variables include psychological
factors such as expectations, psychological mindedness, motivation, hope, and
locus of control. From this perspective, therapists simply act as contributors to set and setting of
naturally occurring client change processes. Similarly, psychedelics, when taken for the "right"
reasons in the right settings also activate inner wisdom in the experiencer. As four of the five
processes in the I-5 model are inherent within the experiencer, a focus on these variables may
further our understanding of the change process in conventional psychotherapy.
References
Fadiman, J.R. (1965). Behavior change following psychedelic (LSD) therapy. Unpublished doctoral
dissertation, Stanford University. Stanford, CA.
Grof, S. (1975). Realms of the human unconscious: Observations from LSD research. New York:
Viking Press.
Hubble, M.A., Duncan, B.L., & Miller, S.D. (1999). The heart and soul of change: What works in
therapy. Washington, D.C.: American Psychological Association.
Leuner, H. (1967). Present state of psycholytic therapy and its possibilities. In H.A. Abramson (Ed.).
The use of LSD in psychotherapy and alcoholism (pp. 101-116). Indianapolis, IN: Bobbs-Merrill Co.
Masters, R.E.L., & Houston, J. (1966). The varieties of psychedelic experience. New York: Dell
Publishing Co.
Sherwood, J.N., Stolaroff, M.J., & Harman, W.W. (1962). The psychedelic experience--a new
concept in psychotherapy. Journal of Neuropsychiatry, 4, 69-80.
Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for
developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.
Dr. House currently works as a therapist in Auckland, New Zealand.
|
| |
| Summer 2008 |
Vol. 18, No. 2 |
Phoenix Rising: A Review of MAPS Research |
| Winter 2008 |
Vol. 18, No. 1 |
Special Edition: Technology and Psychedelics |
| Winter 2007 |
Vol. 17, No. 3 |
MAPS 06-07 Fiscal Yearly Report |
| Autumn 2007 |
Vol. 17, No. 2 |
Special Edition: Psychedelics and Self-Discovery |
| Spring/Summer 2007 |
Vol. 17, No. 1 |
The Chrysalis Stage |
| Winter 2006-7 |
Vol. 16, No. 3 |
Low Maintenance/High Performance |
| Autumn 2006 |
Vol. 16, No. 2 |
Technologies of Healing |
| Spring 2006 |
Vol. 16, No. 1 |
MAPS' 20th Anniversary |
| Winter 2005 |
Vol. 15, No. 3 |
MAPS final year as a teenager |
| Summer 2005 |
Vol. 15, No. 2 |
Israel Conference: MDMA/PTSD Research |
| Spring 2005 |
Vol. 15, No. 1 |
Accelerating flow of work and time |
| Autumn 2004 |
Vol. 14, No. 2 |
Rites of Passage: Kids and Psychedelics |
| Summer 2004 |
Vol. 14, No. 1 |
10 stamps and $250,000 |
| Winter 2003 |
Vol. 13, No. 2 |
Holy Fire |
| Spring 2003 |
Vol. 13, No. 1 |
60th Anniversary of the Discovery
of LSD |
| Autumn 2002 |
Vol. 12, No. 3 |
Vision |
| Summer 2002 |
Vol. 12, No. 2 |
"From celebration to frustration,
and back again." |
| Spring 2002 |
Vol. 12, No. 1 |
Sex, Spirit & Psychedelics 2002 |
| Autumn 2001 |
Vol. 11, No. 2 |
"In the future, it will be called
Despair." |
| Spring 2001 |
Vol. 11, No. 1 |
"A Tidal Wave of Ecstasy!" |
| Autumn 2000 |
Vol. 10, No. 3 |
Creativity 2000 |
| Summer 2000 |
Vol. 10, No. 2 |
Endings and Beginnings |
| Spring 2000 |
Vol. 10, No. 1 |
Making History in Slow Motion |
| Winter 1999/00 |
Vol. 9, No. 4 |
To the Ends of the Earth for MDMA
Research... |
| Autumn 1999 |
Vol. 9, No. 3 |
MAPS' long-standing efforts to conduct... |
| Summer 1999 |
Vol. 9, No. 2 |
MAPS has come full circle... |
| Spring 1999 |
Vol. 9, No. 1 |
Patience, persistence and passion |
| Winter 1998/99 |
Vol. 8, No. 4 |
One of special pleasures of directing
MAPS... |
| Autumn 1998 |
Vol. 8, No. 3 |
The Ayahuasca Issue (with Hofmann
interview) |
| Summer 1998 |
Vol. 8, No. 2 |
Emotionally Powerful Anecdotes... |
| Spring 1998 |
Vol. 8, No. 1 |
Death Has a Way of Focusing One's
Attention |
| Autumn 1997 |
Vol. 7, No. 4 |
Celebration is in Order |
| Summer 1997 |
Vol. 7, No. 3 |
Time Horizons |
| Spring 1997 |
Vol. 7, No. 2 |
Synchronicity |
| Winter 1996/97 |
Vol. 7, No. 1 |
Learning to Crawl |
| Autumn 1996 |
Vol. 6, No. 4 |
An Invitation for Dialogue |
| Summer 1996 |
Vol. 6, No. 3 |
Budding Research |
| New Year 1996 |
Vol. 6, No. 2 |
Sending Down Roots |
| Autumn 1995 |
Vol. 6, No. 1 |
Baby Steps |
| Summer 1995 |
Vol. 5, No. 4 |
Opportunity Amidst Obstacles |
| Winter 1994/95 |
Vol. 5, No. 3 |
Clinical Trials and Tribulations |
| Autumn 1994 |
Vol. 5, No. 2 |
Building Towards Clinical Trials |
| Summer 1994 |
Vol. 5, No. 1 |
Politics and Protocols: In Search
of a Balance |
| Spring 1994 |
Vol. 4, No. 4 |
Laying the Groundwork |
| Winter 1993/94 |
Vol. 4, No. 3 |
A Time of Tests |
| Summer 1993 |
Vol. 4, No. 2 |
So Close Yet So Far |
| Spring 1993 |
Vol. 4, No. 1 |
Remembrance and Renewal |
| Winter 1992/93 |
Vol. 3, No. 4 |
Forging New Alliances |
| Summer 1992 |
Vol. 3, No. 3 |
Building on Common Ground |
| Spring 1992 |
Vol. 3, No. 2 |
Small Steps, Gradual Progress, New
Opportunities |
| Winter 1991/92 |
Vol. 3, No. 1 |
The Rekindling of a Thousand Points
of Light |
| Summer 1991 |
Vol. 2, No. 2 |
MDMA protocol development with cancer patients |
| Winter 1990/91 |
Vol. 2, No. 1 |
MAPS' Swiss pharmacologically-assisted psychotherapy
conference |
| Autumn 1990 |
Vol. 1, No. 3 |
What and Who is MAPS? |
| Summer 1989 |
Vol. 1, No. 2 |
Switzerland Leads the Way |
| Summer 1988 |
Vol. 1, No. 1 |
MDMA can become a legal medicine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|